OIG Issues General Compliance Program Guidance
On November 6, 2023, the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG), in connection with the November 2023 Health Care Compliance Association’s (HCCA) Healthcare Enforcement Compliance Conference, published the General Compliance Program Guidance (GCPG) as a revised reference guide for the healthcare compliance community and other healthcare stakeholders. During [...]
Legislative Watch Updates
MediSpend’s Advisory Services team recently presented a webinar on emerging transparency updates and requirements for pharmaceutical and medical device manufacturers. Notable updates included changes to the Centers for Medicare & Medicaid Services (CMS) Open Payments reporting, Connecticut’s new sales representative disclosure requirements and an update on the Italian Sunshine Act. CMS Open Payments Updates Numerous [...]
CMS Publishes 2022 Open Payments Data
The Centers for Medicare and Medicaid Services (CMS) recently published their 2022 Open Payments data as well as newly submitted and updated payment records for previous program years. The 2022 publication includes transactions that took place between January 1st and December 31st. Applicable manufacturers reported $12.59 billion in reportable payments, ownership and investment interests to [...]
Getting Ahead of Transparency Reporting Webcast
MediSpend's Suj Patel and Frank Madden discuss ways to get and stay ahead of global transparency reporting obligations.
Sanctions Screening Service is a Win-Win for Life Sciences Organizations
Life sciences organizations are subject to numerous legal and regulatory requirements, including an obligation to screen the healthcare professionals and organizations (HCP/Os) that they contract and engage with to ensure they are not caught off guard by any infractions that exist, a process known as sanctions screening. Sanctions screening involves verifying these individuals and entities [...]
Legislative Watch Updates Around the Globe
Recently, MediSpend’s Advisory Services team presented a webinar on emerging transparency updates and requirements for pharmaceutical and medical device manufacturers. Notable updates included changes to the Centers for Medicare & Medicaid Services (CMS) Open Payments reporting, Oregon’s new sales representative disclosure requirements, the Italian Sunshine Act and the Chilean Chamber of Pharmaceutical Innovation (CIF) disclosure [...]
Introducing MediSpend’s 2022 Cultural Representatives
At MediSpend, we’re on a mission to empower life sciences companies to grow their business compliantly through our best-in-class software solutions and top-rated client services. To achieve this mission, we’ve assembled an incredible team and have laid a foundation of cultural attributes that help us make a difference in the life sciences industry. Each year, [...]
MediSpend Reports Exponential Growth in 2021
January 18, 2022 Portsmouth, NH — MediSpend, a global technology company providing best-in-class solutions that empower life sciences companies to grow their business compliantly, reports another year of record-breaking growth with the addition of various new clients totaling nearly 150 life sciences companies leveraging the MediSpend Global Compliance Suite. With support from their new investor, [...]
MediSpend Provides Glimpse into the Future
Continued rapid growth leading to new innovations that further enable compliant HCP engagements. Portsmouth, NH - July 27, 2021— MediSpend, a global technology company providing advanced, best-in-class compliance solutions for the life sciences industry, provides a glimpse into the future as rapid growth continues to fuel new product development and an expanded partner program further [...]
MediSpend Receives Majority Growth Investment From Susquehanna Growth Equity
SGE's investment will support MediSpend's ability to grow its best-in-class compliance solutions across the life sciences industry Portsmouth, NH May 26, 2021 —MediSpend, a global technology company providing best-in-class solutions for the life sciences industry, today announced that it has received a majority investment from Susquehanna Growth Equity, LLC (SGE), an entrepreneur-centric growth equity firm [...]